Trademark: 79374328
Word

Status
Pending
Status Code
641
Status Date
Wednesday, February 28, 2024
Serial Number
79374328
Mark Type
2000
Filing Date
Sunday, May 7, 2023
Trademark Owner History
Matterhorn Biosciences AG
Classifications
5 Pharmaceutical products for cell therapy, immunotherapy and T-cell therapy for preventing and treating cancer, tumors, as well as diseases and disorders of the immune system
44 Medical services in the field of cell therapy, immunotherapy and T-cell therapy
42 Scientific and technological services and research in the field of cell therapy, immunotherapy and T-cell therapy
Trademark Events
Mar 18, 2024
Refusal Processed By Ib
Feb 28, 2024
Non-Final Action Mailed - Refusal Sent To Ib
Feb 28, 2024
Refusal Processed By Mpu
Feb 7, 2024
Non-Final Action (Ib Refusal) Prepared For Review
Feb 6, 2024
Non-Final Action Written
Jan 31, 2024
Assigned To Examiner
Jul 21, 2023
Application Filing Receipt Mailed
Jul 17, 2023
New Application Office Supplied Data Entered
Jul 13, 2023
Sn Assigned For Sect 66a Appl From Ib
MATTERHORN BIOSCIENCES
MELLOW SEA
Trademark Alertz updated from USPTO on 2030-01-24

Trademark Alertz ™ - GRJR PTY LTD 2024 - Privacy Policy - Terms of Use

The information provided on Trademark Alertz is not legal or professional advice. Information may have been obtained from third parties and may contain errors. You must make your own enquiries and seek independent advice from relevant industry professionals before acting or relying on any information from Trademark Alertz. All trade mark information has been obtained from and made publicly available by The United States Patent and Trademark Office (USPTO). Copyright of the trademark data resides with USPTO. www.uspto.gov